Overview Dividends

(RKLB) Rocket Lab USA - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7731211089

Launch Services, Spacecraft Components, Small Rockets, Constellation Management

Industrial Machinery & Supplies & Components
Market Cap in USD: 29,598m

IPO / Inception: 2021-08-24
Return 12m vs S&P 500: 158%

EPS (Earnings per Share)

EPS CAGR: -8.06%
EPS Trend: -44.8%

Last SUE: 3.63
Qual. Beats: 1

Revenue

Rev. CAGR: 58.64%
Rev. Trend: 94.6%

Last SUE: 0.97
Qual. Beats: 2

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	89.5%
Value at Risk 5%th	132%
Relative Tail Risk	-10.28%

Reward TTM
Sharpe Ratio	1.65
Alpha	140.72
CAGR/Max DD	3.03

Character TTM
Hurst Exponent	0.622
Beta	2.297
Beta Downside	2.235

Drawdowns 3y
Max DD	55.49%
Mean DD	23.78%
Median DD	23.04%

Description: RKLB Rocket Lab USA December 17, 2025

Rocket Lab Corporation (NASDAQ:RKLB) is a U.S.-based space launch and spacecraft systems provider that operates in North America, Japan, and globally. It offers end-to-end services-including launch operations, spacecraft design, component manufacturing, on-orbit management, and constellation oversight-while producing its own small-launch vehicle, Electron, and developing the larger-capacity Neutron rocket for constellation deployment, interplanetary missions, and potential human spaceflight.

Key recent metrics: in FY 2023 the company generated roughly $224 million in revenue and completed 30+ dedicated launches, reflecting a ~15% year-over-year increase in launch cadence. The small-sat launch market is expanding at an estimated 12-15% CAGR, driven by the proliferation of LEO broadband constellations and government demand for rapid, responsive access to space. Rocket Lab’s Neutron vehicle, slated for a first flight in 2025, is positioned to capture a share of the emerging medium-class launch segment, competing directly with SpaceX’s Falcon 9 rideshare slots and emerging European providers.

For a deeper dive into Rocket Lab’s valuation metrics and peer comparison, the ValueRay platform offers a concise, data-rich overview.

Piotroski VR‑10 (Strict, 0-10) 1.5

Net Income (-197.6m TTM) > 0 and > 6% of Revenue (6% = 33.3m TTM)

FCFTA -0.10 (>2.0%) and ΔFCFTA 2.12pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 162.7% (prev 117.2%; Δ 45.48pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.05 (>3.0%) and CFO -103.4m > Net Income -197.6m (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 3.18 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (528.7m) change vs 12m ago 6.23% (target <= -2.0% for YES)

Gross Margin 31.70% (prev 26.06%; Δ 5.63pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 32.87% (prev 31.55%; Δ 1.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -31.21 (EBITDA TTM -190.4m / Interest Expense TTM 7.33m) >= 6 (WARN >= 3)

Altman Z'' -0.73

(A) 0.41 = (Total Current Assets 1.32b - Total Current Liabilities 414.5m) / Total Assets 2.22b

(B) -0.43 = Retained Earnings (Balance) -959.0m / Total Assets 2.22b

(D) -1.02 = Book Value of Equity -961.0m / Total Liabilities 940.4m

Total Rating: -0.73 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 31.78

1. Piotroski 1.50pt

2. FCF Yield -0.79%

3. FCF Margin -41.76%

4. Debt/Equity 0.40

5. Debt/Ebitda 1.53

6. ROIC - WACC (= -20.57)%

7. RoE -28.40%

8. Rev. Trend 94.61%

9. EPS Trend -44.76%

What is the price of RKLB shares?

As of December 21, 2025, the stock is trading at USD 70.52 with a total of 51,928,039 shares traded.
Over the past week, the price has changed by +14.69%, over one month by +61.67%, over three months by +47.56% and over the past year by +203.70%.

Is RKLB a buy, sell or hold?

Rocket Lab USA has received a consensus analysts rating of 4.13. Therefore, it is recommended to buy RKLB.

Strong Buy: 7
Buy: 3
Hold: 5
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the RKLB price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	65.7	-6.9%
Analysts Target Price	65.7	-6.9%
ValueRay Target Price	83.3	18.1%

RKLB Fundamental Data Overview December 17, 2025

Market Cap USD = 29.60b (29.60b USD * 1.0 USD.USD)
P/S = 53.3737
P/B = 23.1054
Beta = 2.209
Revenue TTM = 554.5m USD
EBIT TTM = -228.6m USD
EBITDA TTM = -190.4m USD
Long Term Debt = 398.3m USD (from longTermDebt, last quarter)
Short Term Debt = 17.1m USD (from shortTermDebt, last quarter)
Debt = 516.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -291.3m USD (from netDebt column, last quarter)
Enterprise Value = 29.14b USD (29.60b + Debt 516.6m - CCE 976.7m)
Interest Coverage Ratio = -31.21 (Ebit TTM -228.6m / Interest Expense TTM 7.33m)
FCF Yield = -0.79% (FCF TTM -231.6m / Enterprise Value 29.14b)
FCF Margin = -41.76% (FCF TTM -231.6m / Revenue TTM 554.5m)
Net Margin = -35.64% (Net Income TTM -197.6m / Revenue TTM 554.5m)
Gross Margin = 31.70% ((Revenue TTM 554.5m - Cost of Revenue TTM 378.8m) / Revenue TTM)
Gross Margin QoQ = 36.96% (prev 32.10%)
Tobins Q-Ratio = 13.12 (Enterprise Value 29.14b / Total Assets 2.22b)
Interest Expense / Debt = 0.11% (Interest Expense 590.0k / Debt 516.6m)
Taxrate = 69.24% (-41.1m / -59.3m)
NOPAT = -70.3m (EBIT -228.6m * (1 - 69.24%)) [loss with tax shield]
Current Ratio = 3.18 (Total Current Assets 1.32b / Total Current Liabilities 414.5m)
Debt / Equity = 0.40 (Debt 516.6m / totalStockholderEquity, last quarter 1.28b)
Debt / EBITDA = 1.53 (negative EBITDA) (Net Debt -291.3m / EBITDA -190.4m)
Debt / FCF = 1.26 (negative FCF - burning cash) (Net Debt -291.3m / FCF TTM -231.6m)
Total Stockholder Equity = 695.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.90% (Net Income -197.6m / Total Assets 2.22b)
RoE = -28.40% (Net Income TTM -197.6m / Total Stockholder Equity 695.8m)
RoCE = -20.89% (EBIT -228.6m / Capital Employed (Equity 695.8m + L.T.Debt 398.3m))
RoIC = -6.33% (negative operating profit) (NOPAT -70.3m / Invested Capital 1.11b)
WACC = 14.23% (E(29.60b)/V(30.11b) * Re(14.48%) + D(516.6m)/V(30.11b) * Rd(0.11%) * (1-Tc(0.69)))
Discount Rate = 14.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.20%
Fair Price DCF = unknown (Cash Flow -231.6m)
EPS Correlation: -44.76 | EPS CAGR: -8.06% | SUE: 3.63 | # QB: 1
Revenue Correlation: 94.61 | Revenue CAGR: 58.64% | SUE: 0.97 | # QB: 2
EPS next Quarter (2026-03-31): EPS=-0.09 | Chg30d=-0.020 | Revisions Net=+1 | Analysts=7
EPS next Year (2026-12-31): EPS=-0.24 | Chg30d=-0.056 | Revisions Net=-6 | Growth EPS=+36.2% | Growth Revenue=+46.7%

Additional Sources for RKLB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle